来自MSN2 个月
Lentiviral vectors offer gene therapy option for hemophilia A patients with anti-AAV antibodiesThe confounder is that, in the previous study, all 7 had received busulfan and cyclophosphamide conditioning, a regimen known to be leukemogenic. In the current research, treosulfan was used ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果